Inventor
BOHLIN MARTIN
SE24 patents
⚠️ This page may combine multiple inventors who share the name “BOHLIN MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
7 patentsUS6162816ADec 19, 2000
Crystalline form of the S-enantiomer of omeprazole
ASTRAZENECA AB82 citations94
US7273858B2Sep 25, 2007
Salts
ASTRAZENECA AB12 citations79
US7265124B2Sep 4, 2007
Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound
ASTRAZENECA AB13 citations74
US6747155B2Jun 8, 2004
Process
ASTRAZENECA AB8 citations68
US7566788B2Jul 28, 2009
Crystalline forms
ASTRAZENECA AB3 citations62
US7763597B2Jul 27, 2010
Salts
ASTRAZENECA AB0 citations48
US8017785B2Sep 13, 2011
Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine
ASTRAZENECA AB0 citations47
ALBIREO AB
6 patentsUS10975046B2Apr 13, 2021
Crystal modifications of odevixibat
ALBIREO AB22 citations93
US12091394B2Sep 17, 2024
Crystal modifications of odevixibat
ALBIREO AB4 citations84
US11801226B2Oct 31, 2023
Pharmaceutical formulation of odevixibat
ALBIREO AB11 citations84
US11802115B2Oct 31, 2023
Pharmaceutical formulation of odevixibat
ALBIREO AB11 citations84
US11365182B2Jun 21, 2022
Crystal modifications of odevixibat
ALBIREO AB10 citations84
US12508234B2Dec 30, 2025
Pharmaceutical formulation of odevixibat
ALBIREO AB0 citations61
ELOBIX AB
5 patentsUS9745276B2Aug 29, 2017
Crystal modifications of elobixibat
ELOBIX AB53 citations95
US9701649B2Jul 11, 2017
Crystal modifications of elobixibat
ELOBIX AB53 citations95
US9409875B2Aug 9, 2016
Crystal modifications of elobixibat
ELOBIX AB47 citations95
US10183920B2Jan 22, 2019
Crystal modifications of elobixibat
ELOBIX AB24 citations90
US10519120B2Dec 31, 2019
Crystal modifications of elobixibat
ELOBIX AB0 citations48
MIMETOGEN PHARMACEUTICALS INC
4 patentsUS11753441B2Sep 12, 2023
Solution phase synthesis of beta-turn peptidomimetic cyclic salts
MIMETOGEN PHARMACEUTICALS INC2 citations70
US11078234B2Aug 3, 2021
Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts
MIMETOGEN PHARMACEUTICALS INC4 citations70
US10125165B2Nov 13, 2018
Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts
MIMETOGEN PHARMACEUTICALS INC3 citations70
US12281179B2Apr 22, 2025
Solution phase synthesis of β-turn peptidomimetic cyclic salts
MIMETOGEN PHARMACEUTICALS INC0 citations59